Literature DB >> 8647857

Identification of residues 99, 220, and 221 of human cytochrome P450 2C19 as key determinants of omeprazole activity.

G C Ibeanu1, B I Ghanayem, P Linko, L Li, L G Pederson, J A Goldstein.   

Abstract

Human P450 2C19 is selective for 4'-hydroxylation of S-mephenytoin and 5-hydroxylation of omeprazole, while the structurally homologous P450 2C9 has low activity toward these substrates. To identify the critical amino acids that determine the specificity of human amino acids that determine the specificity of human P450 2C19, we constructed chimeras of p450 2C9 replacing various proposed substrate binding sites (SRS) with those of P450 2C19 and then replaced individual residues of P450 2C19 and then replaced individual residues of P450 2C9 by site-directed mutagenesis. The 339 NH2-terminal amino acid residues (SRS-1-SRS-4) and amino acids 160-383 (SRS-2-SRS-5) of P450 2C19 conferred omeprazole 5-hydroxylase activity to P450 2C9. In contract, the COOH terminus of P450 2C19 (residues 340-490 including SRS-5 and SRS-6), residues 228-339 (SRS-3 and SRS-4) and residues 292-383 (part of SRS-4 and SRS-5) conferred only modest increases in activity. A single mutation Ile99 --> His increased omeprazole 5-hydroxylase to approximately 51% of that of P450 2C19. A chimera spanning residues 160-227 of P450 2C19 also exhibited omeprazole 5-hydroxylase activity which was dramatically enhanced by the mutation Ile99 --> His. A combination of two mutations, Ile99 --> His and Ser200 --> Pro, converted P450 2C9 to an enzyme with a turnover number of omeprazole 5-hyrdroxylation, which resembled that of P450 /c19. Mutation of Pro221 --> Thr enhanced this activity. Residue 99 is within SRS-1, but amino acids 220 and 221 are in the F-G loop and outside any known SRS. Mutation of these three amino acids did not confer significant S-mephenytoin 4'-hydroxylase activity to P450 2C9, although chimeras containing SRS-1-SRS-4 and SRS-2-SRS-5 of P450 2C19 exhibited activity toward this substrate. Our results thus indicate that amino acids 99, 220, and 221 are key residues that determine the specificity of P450 2C19 for omeprazole.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647857     DOI: 10.1074/jbc.271.21.12496

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Correlating structure and function of drug-metabolizing enzymes: progress and ongoing challenges.

Authors:  Eric F Johnson; J Patrick Connick; James R Reed; Wayne L Backes; Manoj C Desai; Lianhong Xu; D Fernando Estrada; Jennifer S Laurence; Emily E Scott
Journal:  Drug Metab Dispos       Date:  2013-10-15       Impact factor: 3.922

2.  Structural characterization of human cytochrome P450 2C19: active site differences between P450s 2C8, 2C9, and 2C19.

Authors:  R Leila Reynald; Stefaan Sansen; C David Stout; Eric F Johnson
Journal:  J Biol Chem       Date:  2012-11-01       Impact factor: 5.157

3.  Engineering human cytochrome P450 enzymes into catalytically self-sufficient chimeras using molecular Lego.

Authors:  Vikash Rajnikant Dodhia; Andrea Fantuzzi; Gianfranco Gilardi
Journal:  J Biol Inorg Chem       Date:  2006-07-22       Impact factor: 3.358

4.  Key mutations alter the cytochrome P450 BM3 conformational landscape and remove inherent substrate bias.

Authors:  Christopher F Butler; Caroline Peet; Amy E Mason; Michael W Voice; David Leys; Andrew W Munro
Journal:  J Biol Chem       Date:  2013-07-03       Impact factor: 5.157

Review 5.  Physical Studies of P450-P450 Interactions: Predicting Quaternary Structures of P450 Complexes in Membranes from Their X-ray Crystal Structures.

Authors:  James R Reed; Wayne L Backes
Journal:  Front Pharmacol       Date:  2017-01-30       Impact factor: 5.810

6.  Differing Membrane Interactions of Two Highly Similar Drug-Metabolizing Cytochrome P450 Isoforms: CYP 2C9 and CYP 2C19.

Authors:  Ghulam Mustafa; Prajwal P Nandekar; Neil J Bruce; Rebecca C Wade
Journal:  Int J Mol Sci       Date:  2019-09-04       Impact factor: 5.923

7.  Phylogenomics of the benzoxazinoid biosynthetic pathway of Poaceae: gene duplications and origin of the Bx cluster.

Authors:  Leslie Dutartre; Frédérique Hilliou; René Feyereisen
Journal:  BMC Evol Biol       Date:  2012-05-11       Impact factor: 3.260

8.  Few alterations in clinical pathology and histopathology observed in a CYP2C18&19 humanized mice model.

Authors:  Susanne Löfgren; Stina Ekman; Ylva Terelius; Ronny Fransson-Steen
Journal:  Acta Vet Scand       Date:  2008-11-27       Impact factor: 1.695

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.